Heterozygous alterations of GTF2I at the Williams-Beuren syndrome’s locus cause a neurodevelopmental disorder

  • Jeanne Jury
  • , Thomas Besnard
  • , Wallid Deb
  • , Annick Toutain
  • , Paul Gueguen
  • , Ange Line Bruel
  • , Arjan Bouman
  • , Danielle Veenma
  • , Tahsin Stefan Barakat
  • , Laura Do Souto Ferreira
  • , Petra J.G. Zwijnenburg
  • , Sarah Schuhmann
  • , Georgia Vasileiou
  • , Matthieu Egloff
  • , Frédéric Bilan
  • , Anne Mercier
  • , Pascaline Letard
  • , Elsa Leitão
  • , Christopher Schroeder
  • , Christel Depienne
  • Pierre Blanc, Stéphane Bézieau, Benjamin Cogné, Bertrand Isidor*
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose:

Williams-Beuren syndrome (WBS) is a well-known neurodevelopmental disorder caused by a copy-number loss at the 7q11.23 locus. Although the 1.5–1.8Mb recurrent deletion carries several genes of interest, no single gene has been identified in which pathogenic variants cause a neurodevelopmental phenotype. At this locus, GTF2I, encoding the general transcription factor II-I, has been considered as the main candidate gene for the cognitive and behavioural phenotype of WBS, based on clinical observations of cases with atypical 7q.11.23 deletions and functional studies in humans and mice.

Methods:

Individuals with a neurodevelopmental disorder were identified through a multicentre collaboration using GeneMatcher and the ERN-ITHACA network. They remained undiagnosed following genome/exome sequencing. Clinical evaluations were performed in each participating centre. 

Results:

We identified seven unrelated individuals with de novo variants in GTF2I (two non-sense, two splice-site, one missense, one indel and one intragenic deletion). We also identified one individual with a WBS phenotype and low GTF2I expression identified by RNA sequencing. All eight individuals presented with global developmental delay and facial dysmorphic features, with speech delay and/or autistic features in seven cases. The effect of the two splice-site variants was confirmed by RNA sequencing. 

Conclusion:

Pathogenic heterozygous GTF2I variants cause a neurodevelopmental disorder characterised by global developmental delay with facial dysmorphic features, partly resembling the phenotype observed in individuals affected with WBS.

Original languageEnglish
Pages (from-to)34-39
Number of pages6
JournalJournal of medical genetics
Volume63
Issue number1
DOIs
Publication statusE-pub ahead of print - 25 Dec 2025

Bibliographical note

Publisher Copyright:
© Author(s) (or their employer(s)) 2026. No commercial re-use. See rights and permissions. Published by BMJ Group.

Fingerprint

Dive into the research topics of 'Heterozygous alterations of GTF2I at the Williams-Beuren syndrome’s locus cause a neurodevelopmental disorder'. Together they form a unique fingerprint.

Cite this